This even leads to a dominant, Treg-cell-intrinsic anti-tumor function, as the sole transfer of Carma1-deficient Treg cells into immunocompetent recipients, is sufficient to reduce tumor growth in an IFNγ-dependent manner [86]. Here, CARD11 is linked to neoplasm.